Attached files

file filename
8-K - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES - SILICON LABORATORIES INC.a14-4404_18k.htm

Exhibit 99

 

GRAPHIC

 

SILICON LABS ANNOUNCES FOURTH QUARTER AND FISCAL 2013 RESULTS

 

Record Revenue for 2013 —

 

AUSTIN, Texas — Jan. 29, 2014 — Silicon Labs (NASDAQ: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported financial results for its fourth quarter and fiscal year ended Dec. 28, 2013.  Revenue in the fourth quarter was $146.2 million, a slight decrease from the $146.9 million reported in the third quarter. Revenue for fiscal 2013 was a record $580.1 million, compared with $563.3 million in 2012.

 

Q4 Financial Highlights

 

On a GAAP basis:

 

·                  Gross margins increased sequentially to 60.6 percent

·                  R&D investment increased sequentially to $42.2 million

·                  SG&A expenses declined sequentially to $32.3 million

·                  Operating income increased sequentially to 9.7 percent of revenue

·                  Diluted earnings per share increased sequentially to $0.24

 

On a non-GAAP basis (results exclude the impact of stock compensation, amortization from acquired intangible assets and certain other items as set forth in the reconciliation table below):

 

·                  Gross margins increased sequentially to 61.2 percent

·                  R&D expenses increased sequentially to $34.5 million

·                  SG&A expenses declined sequentially to $27.7 million

·                  Operating income increased sequentially to 18.7 percent

·                  Diluted earnings per share increased sequentially to $0.49

 

Business Highlights

 

·                  Broad-based revenue was $72.4 million, reflecting a record quarter in microcontrollers and wireless offset by lower than expected revenue for timing due to general weakness in the telecom infrastructure market.

·                  Broadcast outperformed expectations in the fourth quarter with revenue of $49.6 million.

·                  Access grew slightly in the fourth quarter, exceeding expectations, with revenue of $24.3 million.

·                  During the fourth quarter, the company announced several important mixed-signal products for Internet of Things applications, including the energy-friendly EFM32™ Zero Gecko MCU family, the ultra-low-power Si106x/8x wireless MCU family, and the next-generation Si701x/2x relative humidity and temperature sensor family.

 



 

“We are very pleased with our performance in the fourth quarter, as our microcontroller and wireless products delivered another record revenue quarter, and we experienced better than expected revenue from Broadcast and Access products,” said Tyson Tuttle, CEO of Silicon Labs. “Revenue for 2013 was a record for the company, and we believe we are entering 2014 well positioned in growth markets such as the Internet of Things, smart energy and Internet infrastructure.”

 

Business Outlook

 

The company expects revenue in the first quarter to be in the range of $142 million to $146 million. The company expects first quarter earnings per share to be between $0.14 and $0.18 on a GAAP basis and between $0.40 and $0.44 on a non-GAAP basis.

 

Webcast and Conference Call

 

A conference call discussing the quarterly results will follow this press release at 7:30 a.m. Central time. An audio webcast will be available simultaneously on Silicon Labs’ website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 1 (855) 859-2056 or (404) 537-3406 (international) and by entering 39717387. The replay will be available through March 8.

 

About Silicon Labs

 

Silicon Labs is an industry leader in the innovation of high-performance, analog-intensive, mixed-signal ICs. Developed by a world-class engineering team with unsurpassed expertise in mixed-signal design, Silicon Labs’ diverse portfolio of patented semiconductor solutions offers customers significant advantages in performance, size and power consumption. For more information about Silicon Labs, please visit www.silabs.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing our distributors, manufacturers and subcontractors; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; conflict mineral risks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

 

Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Deborah Stapleton, +1 650.470.4200, Deborah.Stapleton@silabs.com

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

Year Ended

 

 

 

December 28,
2013

 

December 29,
2012

 

December 28,
2013

 

December 29,
2012

 

Revenues

 

$

146,236

 

$

152,461

 

$

580,087

 

$

563,294

 

Cost of revenues

 

57,638

 

58,835

 

227,183

 

225,277

 

Gross margin

 

88,598

 

93,626

 

352,904

 

338,017

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

42,168

 

36,009

 

157,799

 

137,952

 

Selling, general and administrative

 

32,276

 

32,315

 

130,795

 

114,390

 

Operating expenses

 

74,444

 

68,324

 

288,594

 

252,342

 

Operating income

 

14,154

 

25,302

 

64,310

 

85,675

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

237

 

235

 

853

 

1,338

 

Interest expense

 

(807

)

(850

)

(3,293

)

(1,149

)

Other income (expense), net

 

118

 

(323

)

157

 

484

 

Income before income taxes

 

13,702

 

24,364

 

62,027

 

86,348

 

Provision for income taxes

 

3,060

 

5,669

 

12,208

 

22,800

 

Net income

 

$

10,642

 

$

18,695

 

$

49,819

 

$

63,548

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.25

 

$

0.45

 

$

1.17

 

$

1.51

 

Diluted

 

$

0.24

 

$

0.44

 

$

1.14

 

$

1.47

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

42,972

 

41,705

 

42,715

 

42,136

 

Diluted

 

43,847

 

42,641

 

43,537

 

43,106

 

 



 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

 

 

Three Months Ended
December 28, 2013

 

Non-GAAP Income
Statement Items

 

GAAP
Measure

 

GAAP
Percent of
Revenue

 

Stock
Compensation
Expense

 

Intangible
Asset
Amortization

 

Termination
Costs

 

Acquisition
Related
Items

 

Non-
GAAP
Measure

 

Non-
GAAP
Percent of
Revenue

 

Revenues

 

$

146,236

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

88,598

 

60.6

%

$

166

 

$

390

 

$

 

$

400

 

$

89,554

 

61.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

42,168

 

28.8

%

3,979

 

3,217

 

447

 

 

34,525

 

23.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

32,276

 

22.1

%

4,351

 

729

 

895

 

(1,384

)

27,685

 

18.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

14,154

 

9.7

%

8,496

 

4,336

 

1,342

 

(984

)

27,344

 

18.7

%

 

 

 

Three Months Ended
December 28, 2013

 

Non-GAAP Diluted
Earnings Per Share

 

GAAP
Measure

 

Stock
Compensation
Expense

 

Intangible
Asset
Amortization

 

Termination
Costs

 

Acquisition
Related
Items

 

Non-
GAAP
Measure

 

Net income

 

$

10,642

 

$

7,685

 

$

2,986

 

$

1,179

 

$

(1,096

)

$

21,396

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted shares outstanding

 

43,847

 

 

 

 

 

43,847

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.24

 

 

 

 

 

 

 

 

 

$

0.49

 

 

Unaudited Forward-Looking Statements Regarding Business Outlook

(In thousands, except per share information)

 

 

 

Three Months Ending
March 29, 2014

 

Business Outlook

 

High

 

Low

 

Estimated GAAP diluted earnings per share

 

$

0.18

 

$

0.14

 

 

 

 

 

 

 

Estimated non-GAAP charges

 

0.26

 

0.26

 

 

 

 

 

 

 

Estimated non-GAAP diluted earnings per share

 

$

0.44

 

$

0.40

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

 

December 28,
2013

 

December 29,
2012

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

95,800

 

$

105,426

 

Short-term investments

 

179,593

 

176,565

 

Accounts receivable, net of allowances for doubtful accounts of $797 at December 28, 2013 and $670 at December 29, 2012

 

72,124

 

78,023

 

Inventories

 

45,271

 

49,579

 

Deferred income taxes

 

18,878

 

16,652

 

Prepaid expenses and other current assets

 

47,651

 

41,437

 

Total current assets

 

459,317

 

467,682

 

Long-term investments

 

10,632

 

11,369

 

Property and equipment, net

 

132,445

 

135,271

 

Goodwill

 

228,781

 

130,265

 

Other intangible assets, net

 

131,593

 

90,750

 

Other assets, net

 

28,382

 

36,629

 

Total assets

 

$

991,150

 

$

871,966

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

22,126

 

$

29,622

 

Current portion of long-term debt

 

7,500

 

5,000

 

Accrued expenses

 

45,975

 

40,410

 

Deferred income on shipments to distributors

 

30,853

 

30,259

 

Income taxes

 

2,693

 

1,087

 

Total current liabilities

 

109,147

 

106,378

 

Long-term debt

 

87,500

 

95,000

 

Other non-current liabilities

 

55,941

 

20,615

 

Total liabilities

 

252,588

 

221,993

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock — $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock — $0.0001 par value; 250,000 shares authorized; 42,779 and 41,879 shares issued and outstanding at December 28, 2013 and December 29, 2012, respectively

 

4

 

4

 

Additional paid-in capital

 

48,630

 

10,122

 

Retained earnings

 

690,612

 

640,793

 

Accumulated other comprehensive loss

 

(684

)

(946

)

Total stockholders’ equity

 

738,562

 

649,973

 

Total liabilities and stockholders’ equity

 

$

991,150

 

$

871,966

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Year Ended

 

 

 

December 28,
2013

 

December 29,
2012

 

Operating Activities

 

 

 

 

 

Net income

 

$

49,819

 

$

63,548

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

Depreciation of property and equipment

 

13,491

 

13,621

 

Net gain on the purchase of property and equipment

 

 

(8,457

)

Amortization of other intangible assets and other assets

 

15,911

 

14,154

 

Impairment of long-lived assets

 

 

708

 

Stock-based compensation expense

 

30,800

 

31,176

 

Income tax benefit (detriment) from employee stock-based awards

 

(606

)

1,827

 

Excess income tax benefit from employee stock-based awards

 

(290

)

(1,294

)

Deferred income taxes

 

3,319

 

4,725

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

8,972

 

(20,743

)

Inventories

 

5,588

 

(13,056

)

Prepaid expenses and other assets

 

(2,514

)

10,629

 

Accounts payable

 

(3,979

)

7,217

 

Accrued expenses

 

(3,169

)

(3,812

)

Deferred income on shipments to distributors

 

(2,381

)

4,623

 

Income taxes

 

5,189

 

(7,816

)

Net cash provided by operating activities

 

120,150

 

97,050

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

Purchases of available-for-sale investments

 

(213,883

)

(192,450

)

Proceeds from sales and maturities of available-for-sale investments

 

210,824

 

235,517

 

Purchases of property and equipment

 

(10,472

)

(102,043

)

Purchases of other assets

 

(5,939

)

(8,508

)

Acquisitions of businesses, net of cash acquired

 

(86,441

)

(71,852

)

Net cash used in investing activities

 

(105,911

)

(139,336

)

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

Proceeds from issuance of common stock, net of shares withheld for taxes

 

15,301

 

15,148

 

Excess income tax benefit from employee stock-based awards

 

290

 

1,294

 

Repurchases of common stock

 

(26,022

)

(62,019

)

Proceeds from issuance of long-term debt, net

 

 

98,325

 

Payments on debt

 

(13,434

)

 

Net cash provided by (used in) financing activities

 

(23,865

)

52,748

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

(9,626

)

10,462

 

Cash and cash equivalents at beginning of period

 

105,426

 

94,964

 

Cash and cash equivalents at end of period

 

$

95,800

 

$

105,426

 

 

###